Article
Standardized indolent systemic mastocytosis evaluations across a health care system: implications for screening accuracy.
Blood - 25 Jul 2024
McMurray Jeremy C, Pacheco Curtis S, Schornack Brandon J, Sun Xiaoping, Brunader Janet A, Scott Alexis E, Ariza Juan S, Kou Chung-Ting J, Costantino Ryan C, Pittman Luke M, Adams Karla E, Waters Aubri M, Pryor Eric M, Lyons Jonathan J, Metcalfe Dean D, Maric Irina, Boggs Nathan A
Abstract excerpt
ABSTRACT: Timely diagnosis of systemic mastocytosis (SM) remains challenging because of care heterogeneity. We implemented a standardized approach for SM screening and diagnosis using a novel health care system-wide international screening registry. A retrospective analysis assessed rates of SM, cutaneous mastocytosis (CM), and molecular diagnoses before and 2 years after care standardization. The accuracy of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
